USANA HEALTH SCIENCES, INC. Operating Lease, Right-of-Use Asset, Amortization Expense
USANA HEALTH SCIENCES, INC. (USNA) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $3.01 million for the 6-month period ending 2026-07-04, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2026-08-13
- USANA HEALTH SCIENCES, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-07-04 was $1.50M, a 19.61% decline year-over-year.
- USANA HEALTH SCIENCES, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-04-04 was $1.51M, a 20.67% decline year-over-year.
- USANA HEALTH SCIENCES, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-01-03 was $1.73M, a 8.49% decline year-over-year.
- USANA HEALTH SCIENCES, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-09-27 was $1.65M, a 17.19% decline year-over-year.
- USANA HEALTH SCIENCES, INC. operating lease, right-of-use asset, amortization expense for fiscal 2026 was $7.14M, a 7.15% decline from fiscal 2024.
- USANA HEALTH SCIENCES, INC. operating lease, right-of-use asset, amortization expense for fiscal 2024 was $7.69M, a 0.04% decline from fiscal 2023.
- USANA HEALTH SCIENCES, INC. operating lease, right-of-use asset, amortization expense for fiscal 2023 was $7.69M, a 4.04% decline from fiscal 2022.
- USANA HEALTH SCIENCES, INC. operating lease, right-of-use asset, amortization expense for fiscal 2022 was $8.02M, a 12.45% decline from fiscal 2022.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month | Operating Lease, Right-of-Use Asset, Amortization Expense 9 month | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month |
|---|---|---|---|---|
| 2026-07-04 | $1.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $3.01M 10-Q · filed 2026-08-13 | $4.73M derived: sum of 3 quarters · filed 2026-08-13 | $6.38M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-04-04 | $1.51M 10-Q · filed 2026-05-12 | $3.24M derived: sum of 2 quarters · filed 2026-05-12 | $4.88M derived: sum of 3 quarters · filed 2026-05-12 | $6.75M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-01-03 | $1.73M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $3.37M derived: sum of 2 quarters · filed 2026-03-16 | $5.23M derived: sum of 3 quarters · filed 2026-08-13 | $7.14M 10-K · filed 2026-03-16 |
| 2025-09-27 | $1.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $3.51M derived: sum of 2 quarters · filed 2026-08-13 | $5.42M 10-Q · filed 2025-11-05 | $7.30M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-28 | $1.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $3.77M 10-Q · filed 2026-08-13 | $5.65M derived: sum of 3 quarters · filed 2026-08-13 | $7.64M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-29 | $1.91M 10-Q · filed 2026-05-12 | $3.79M derived: sum of 2 quarters · filed 2026-05-12 | $5.78M derived: sum of 3 quarters · filed 2026-05-12 | $7.67M derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-28 | $1.89M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $3.88M derived: sum of 2 quarters · filed 2026-03-16 | $5.76M derived: sum of 3 quarters · filed 2026-03-16 | $7.69M 10-K · filed 2026-03-16 |
| 2024-09-28 | $1.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $3.88M derived: sum of 2 quarters · filed 2025-11-05 | $5.80M 10-Q · filed 2025-11-05 | $7.76M derived: sum of 4 quarters · filed 2026-03-16 |
| 2024-06-29 | $1.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $3.81M 10-Q · filed 2025-08-05 | $5.77M derived: sum of 3 quarters · filed 2026-03-16 | $7.66M derived: sum of 4 quarters · filed 2026-03-16 |
| 2024-03-30 | $1.93M 10-Q · filed 2025-05-06 | $3.88M derived: sum of 2 quarters · filed 2026-03-16 | $5.77M derived: sum of 3 quarters · filed 2026-03-16 | $7.69M derived: sum of 4 quarters · filed 2026-03-16 |
| 2023-12-30 | $1.96M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $3.85M derived: sum of 2 quarters · filed 2026-03-16 | $5.77M derived: sum of 3 quarters · filed 2026-03-16 | $7.69M 10-K · filed 2026-03-16 |
| 2023-09-30 | $1.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $3.81M derived: sum of 2 quarters · filed 2024-11-05 | $5.73M 10-Q · filed 2024-11-05 | $7.69M derived: sum of 4 quarters · filed 2025-03-12 |
| 2023-07-01 | $1.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $3.85M 10-Q · filed 2024-08-06 | $5.81M derived: sum of 3 quarters · filed 2025-03-12 | $7.76M derived: sum of 4 quarters · filed 2025-03-12 |
| 2023-04-01 | $1.93M 10-Q · filed 2024-05-07 | $3.88M derived: sum of 2 quarters · filed 2025-03-12 | $5.84M derived: sum of 3 quarters · filed 2025-03-12 | $7.62M derived: sum of 4 quarters · filed 2025-03-12 |
| 2022-12-31 | $1.96M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-12 | $3.91M derived: sum of 2 quarters · filed 2025-03-12 | $5.69M derived: sum of 3 quarters · filed 2025-03-12 | $8.02M 10-K · filed 2025-03-12 |
| 2022-10-01 | $1.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $3.73M derived: sum of 2 quarters · filed 2023-11-07 | $6.06M 10-Q · filed 2023-11-07 | $8.44M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-07-02 | $1.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $4.11M 10-Q · filed 2023-08-08 | $6.48M derived: sum of 3 quarters · filed 2024-02-27 | $8.72M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-04-02 | $2.33M 10-Q · filed 2023-05-09 | $4.71M derived: sum of 2 quarters · filed 2024-02-27 | $6.95M derived: sum of 3 quarters · filed 2024-02-27 | $9.22M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-01-01 | $2.38M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $4.62M derived: sum of 2 quarters · filed 2024-02-27 | $6.90M derived: sum of 3 quarters · filed 2024-02-27 | $9.16M 10-K · filed 2024-02-27 |
| 2021-10-02 | $2.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $4.52M derived: sum of 2 quarters · filed 2022-11-08 | $6.78M 10-Q · filed 2022-11-08 | |
| 2021-07-03 | $2.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $4.54M 10-Q · filed 2022-08-09 | ||
| 2021-04-03 | $2.26M 10-Q · filed 2022-05-11 | |||
| 2021-01-02 | $8.76M 10-K · filed 2023-02-28 | |||
| 2019-12-28 | $8.26M 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |